The European Clinical Research Alliance on Infectious Diseases (ECRAID) focuses on two major challenges: emerging infectious diseases (EID) with epidemic or pandemic potential, caused by new or re-emerging pathogens, and antimicrobial resistance (AMR). This meeting aims to bring together the ECRAID-Plan Project Consortium, Working Group, and key stakeholders to constructively discuss ECRAID and its sustainable solutions to protect Europe, and beyond, from AMR and EID threats over the long-term.  This is a closed meeting.

Kevin Outterson, Executive Director of CARB-X, will be on the stakeholder advisory panel.  Keynote speakers include EU Commissioner for Research, Science and Innovation, Carlos Moedas, and Wellcome Trust Director, Jeremy Farrar.